Amicus Therapeutics Inc.

7.95
-0.21 (-2.57%)
At close: Apr 01, 2025, 3:59 PM
8.05
1.34%
After-hours: Apr 01, 2025, 07:41 PM EDT

Amicus Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
PE Ratio -51.1 -27.63 -14.92 -12.52 -21.59 -6.57 -5.1 -7.77 -3.34 -8.07 -8.99 -2.02 -2.5 -2.68 -2.37 -13.68 -4.56 -3.46 -0.23 -0.3 -0.5 -0.66
PEG Ratio 0.79 0.73 1.37 0.89 0.78 0.31 -3.14 -0.32 -0.14 -0.28 0.45 -0.24 0.15 0.08 -0.00 0.16 0.10 0.04 -0.01 -0.00 -0.02 n/a
PS Ratio 5.43 10.49 10.72 10.26 22.91 12.85 19.51 59.76 134.73 n/a 506.03 332.02 6.63 5.55 141.38 1.40 11.99 79.76 n/a n/a n/a n/a
PB Ratio 14.78 26.15 28.68 10.20 20.87 4.92 5.19 6.25 1.85 3.07 5.07 2.63 1.76 4.02 2.01 1.25 2.53 1.38 -0.14 -0.17 n/a -0.84
P/FCF Ratio -76.57 -54.73 -20.72 -15.19 -25.27 -8.66 -5.81 -10.03 -4.27 -10.16 -11.93 -2.59 -3.21 -2.34 -9.07 -1.99 -4.54 9.80 -0.3 -0.28 n/a n/a
P/OCF Ratio -84.6 -60.62 -21.19 -15.48 -25.62 -9.35 -5.93 -10.24 -4.44 -10.65 -11.99 -2.63 -3.62 -2.41 -9.32 -2.07 -4.87 9.37 -0.31 -0.33 n/a n/a
OCF/S Ratio -0.06 -0.17 -0.51 -0.66 -0.89 -1.37 -3.29 -5.83 -30.36 n/a -42.21 -126.15 -1.83 -2.31 -15.17 -0.67 -2.46 8.52 n/a n/a n/a n/a
Debt / Equity Ratio 2.29 2.78 3.67 1.43 1.54 0.44 0.94 0.47 0.43 0.12 0.12 0.32 0.01 0.04 0.04 0.05 0.02 0.03 -0.05 -0.03 n/a n/a
Quick Ratio 2.60 2.52 2.88 3.90 4.32 3.93 6.30 5.53 3.03 2.94 7.66 8.44 11.32 3.46 6.76 7.19 9.24 10.32 5.39 9.59 n/a n/a
Current Ratio 3.39 2.88 3.05 4.09 4.47 4.04 6.40 5.60 3.06 2.94 7.66 8.44 11.32 3.46 6.76 7.19 9.24 10.32 5.39 9.59 n/a n/a
Asset Turnover 0.67 0.51 0.45 0.34 0.29 0.21 0.12 0.06 0.00 n/a 0.01 0.00 0.17 0.31 0.01 0.75 0.12 0.01 n/a n/a n/a n/a
Interest Coverage 0.50 -1.47 -5.51 -6.16 -10.87 -15.94 -14.68 -25.64 -33.7 -82.66 -46.29 -1.4K -594.73 -343.83 -214.76 -26.44 -201.63 n/a n/a n/a n/a n/a
Return on Equity (ROE) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Assets (ROA) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Capital (ROIC) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 89.98% 90.65% 88.28% 88.72% 88.10% 87.95% 84.21% 83.11% 83.20% n/a 100.00% -3.62K% -10.68% 100.00% 100.00% 100.00% 100.00% 100.00% n/a n/a n/a n/a
Net Profit Margin -10.62% -37.96% -71.85% -81.98% -106.12% -195.56% -382.48% -769.03% -4.03K% n/a -5.63K% -16.43K% -264.98% -207.2% -5.96K% -10.2% -262.95% -2.31K% n/a n/a n/a n/a
Pretax Profit Margin -5.44% -37.59% -73.52% -79.06% -105.12% -195.3% -382.58% -1.22K% -4.11K% n/a -5.72K% -17.4K% -282.6% -224.13% -6.08K% -10.2% -262.95% -2.31K% n/a n/a n/a n/a
Operating Profit Margin 4.71% -18.4% -62.09% -65.44% -93.47% -165.03% -360.32% -1.2K% -3.67K% n/a -5.61K% -17.68K% -287.5% -237.41% -6.06K% -11.42% -293.69% -2.57K% n/a n/a n/a n/a
FCF Margin -7.09% -19.16% -51.74% -67.55% -90.66% -148.39% -335.65% -595.75% -3.16K% n/a -4.24K% -12.81K% -206.77% -237.2% -1.56K% -70.2% -264.11% 814.07% n/a n/a n/a n/a
EBITDA Margin 5.56% -23.06% -60.62% -66.4% -93.14% -182.32% -353.41% -1.16K% -3.94K% n/a -5.47K% -16.91K% -272.86% -217.12% -5.83K% -6.46% -251.51% -2.5K% n/a n/a n/a n/a